Global X S&P Biotech ETF is a sector & thematic ETF from Global X — 157 holdings, with $39.6m under management. 78% of its money is in health care. Its two largest holdings, MODERNA INC and TWIST BIOSCIENCE, make up 4% of the fund. It charges 0.45% a year.
Compare CURE with another fund →PCVX
VAXCYTE INC
Health Care · United States · 1.19% of CURE on average
Contributed +$25 per $10k to CURE over the last month.
Loading…
Explained moves, and what each did to CURE
About CURE
- TypeSector & thematic
- IssuerGlobal X
- Size$39.6m
- Cost0.45% a year
- Holdings157
- Top sectorHealth Care 78%
- Top 2 holdings4%
CURE rose 0.7% over the last month. On $10,000, that's +$71. QURE was the biggest drag at −$43; MRNA helped most at +$132.
What moved it
Gain or loss per $10k invested
- MRNAModerna+$132
- IOVAIovance+$78
- GRALGrail+$73
- TWSTTwist+$47
- QUREUniqure−$43
- TVTXTravere−$33
- IBRXImmunitybio+$33
- NTRANatera+$33
- PRAXPraxis−$32
- INSMInsmed−$29
- ARWRArrowhead−$29
- DNTHDianthus−$27
- SRRKScholar Rock−$27
- PCVXVaxcyte+$25
- RXRXRecursion+$23
- BMRNBiomarin−$23
- ACADAcadia Pharma−$21
- CELCCelcuity−$20
- ROIVRoivant−$18
- CYTKCytokinetics−$17
- NKTRNektar−$17
- IMVTImmunovant−$16
- MDGLMadrigal−$16
- SLSSellas Life−$16
- ALKSAlkermes−$15
- ORKAOruka−$15
- UTHRUnited Thera.+$14
- INCYIncyte−$12
- AMGNAmgen+$11
- ABBVAbbVie+$11
- RVMDRevolution−$9
- REGNRegeneron−$8
- EXELExelixis+$6
- BIIBBiogen+$6
- GILDGilead+$6
- SYRESpyre−$6
- HALOHalozyme+$5
- KRYSKrystal−$4
- CRSPCrispr−$1
- PTGXProtagonist−$1
- VRTXVertex Pharma−$1
- TGTXTg Thera.−$1
- CurrencyForeign currencies against the Australian dollar+$217
- UnattributedHedging, fees, timing−$51
- CompoundingDaily returns multiply, they do not add−$34
- Fund return+$71
- Other 7 kinds of news−$4
- Other 5 kinds of news+$3
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.